Skip to content
Disclosery

ORBIMED ADVISORS LLC: ELVN position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on ELVN, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 6,776,632 ELVN shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 6,776,632 shares
    Change vs previous 13F -1,182,906 shares

    6.51% of the 13F portfolio, value $343,914,074.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 7,959,538 shares
    Change vs previous 13F 0 shares

    6.8% of the 13F portfolio, value $312,013,890.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 7,959,538 shares
    Change vs previous 13F 0 shares

    2.51% of the 13F portfolio, value $122,576,885.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 7,959,538 shares
    Change vs previous 13F 0 shares

    3.91% of the 13F portfolio, value $162,931,743.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 7,959,538 shares
    Change vs previous 13F 0 shares

    4.02% of the 13F portfolio, value $159,668,332.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 7,959,538 shares
    Change vs previous 13F 0 shares

    3.76% of the 13F portfolio, value $156,643,708.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 7,959,538 shares
    Change vs previous 13F 0 shares

    3.72% of the 13F portfolio, value $179,089,605.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 7,959,538 shares
    Change vs previous 13F not available

    3.72% of the 13F portfolio, value $203,286,601.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).